Cowen Reiterates Outperform on SuperCom (SPCB) Following Preliminary 3Q Revenue

Go back to Cowen Reiterates Outperform on SuperCom (SPCB) Following Preliminary 3Q Revenue

Feltl & Co Downgrades SuperCom (SPCB) to Buy

November 30, 2015 12:56 PM EST

Feltl & Co downgraded SuperCom (NASDAQ: SPCB) from Strong Buy to Buy with a price target of $8.00.

For an analyst ratings summary and ratings history on SuperCom click here. For more ratings news on SuperCom click here.

Shares of SuperCom closed at $7.70 yesterday.

... More

Unusual 11 Mid-Day Movers 11/30: (HART) (AVXL) (HCLP) Higher; (SPCB) (CCYC) (EFUT) Lower

November 30, 2015 12:52 PM EST

SuperCom Ltd. (Nasdaq: SPCB) 38.2% LOWER; reported preliminary Q3 revenue of $5.5 to $6.1 million, with consensus estimates at $13.4 million.

Harvard Apparatus (Nasdaq: HART) 33.1% HIGHER; making a strong move back above the $3 level today.

Anavex Life Sciences Corp. (Nasdaq: AVXL) 29.1% HIGHER; announced the publication of further data for ANAVEX 3-71 (formerly AF710B) in the peer-reviewed scientific journal Neurodegenerative Diseases.... More

SuperCom's (SPCB) Prelim. Q3 Revenue Falls Short of Consensus

November 30, 2015 8:14 AM EST

SuperCom Ltd. (NASDAQ: SPCB), a global provider of secure solutions for the e-Government, Public Safety, HealthCare, and Finance sectors, provided preliminary revenue for the third quarter ended September 30, 2015, and updated guidance for the full year of 2015.

Based on preliminary estimates, revenue for the quarter ended September 30, 2015 is anticipated to be in a range of $5.5 million to $6.1 million. Cash and cash-equivalents were approximately $35 million as of September 30, 2015. The Company is... More

Trading Radar for 11/30: Shoe Carnival (SCVL), NQ Mobile (NQ), Infoblox (BLOX), uniQure (QURE) Report

November 27, 2015 11:27 AM EST

The Trading Radar highlights key earnings and economic announcements for the next trading session:

Before Markets Open:
Earnings:

58.com (NYSE: WUBA) - consensus loss $0.72
Actions Semiconductor (Nasdaq: ACTS) - no Street consensus... More